Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Cbc Group
BioCentury | Mar 18, 2025
Management Tracks
Zenas names Lisa von Moltke head of R&D and CMO
Plus: CBC’s Lan Kang becomes CEO of Azkarra, and updates from Ionctura, Sunbird and Surf Bio
BioCentury | Jan 14, 2025
Deals
JPM ushers in flurry of biotech deals, headlined by J&J’s Intra-cellular buy
BioCentury’s Deals Report surveys deals by GSK, Idrx, Lilly, Scorpion, Lantheus, Telix, Gilead, Leo, CBC Group and more
BioCentury | Aug 27, 2024
Deals
Deals Report: Selling assets to CBC and Mubadala, UCB turns China focus to innovation
Plus: A pair of ADC deals between Merck-Kelun, Adcendo-Multitude
BioCentury | Jul 16, 2024
Management Tracks
More moves at the top for I-Mab
Plus: Daniel Janse named CEO at AffyImmune, and updates from HanAll, Mogrify, Rectify and Atsena
BioCentury | Apr 10, 2024
Management Tracks
PureTech’s Zohar takes CEO role at new portfolio company targeting CNS
Plus: AskBio hires former Prevail CSO, and updates from Illumina, Xencor, Adcentrx, enGene and more
BioCentury | Jan 30, 2024
Product Development
Singapore’s next challenge: turning momentum into sustainable growth
The island nation has caught the interest of international investors and pharmas. Will this be the moment its biotech accelerates?
BioCentury | Oct 25, 2023
Finance
Oct. 25 Quick Takes: U.K. takes next step in pension fund reforms
Plus: CBC-backed R-Bridge realizes royalty exit, and updates from Akebia, DermBiont, GSK and Flashpoint
BioCentury | Aug 9, 2023
Management Tracks
AI Proteins names Noah Beerman as CEO, Alles chair
Plus: Emergent cuts include COO, and updates from Playground, Viracta, Dunad
BioCentury | Jul 11, 2023
Management Tracks
Billy Cho joins CBC as senior managing director
Plus: Birchenough becomes chairman of global healthcare at Barclays, and updates from EyePoint, Replicate, MBX, Voyager and more
BioCentury | Apr 20, 2023
Finance
April 20 Quick Takes: Hasten prepares for acquisitions with $315M raise
Plus: BMS, Tubulis partner and updates from BeiGene, Day One and Enveda
Items per page:
1 - 10 of 46